| Financial Year |
March 31 2023 |
| Monetary Funds |
1,644,286,122.07 |
| Held-for-trading Financial Assets |
963,843.54 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,749,119,559.29 |
| Advances to Suppliers |
353,898,062.12 |
| Other Receivables |
301,520,482.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
69,752,774.58 |
| Inventories |
796,451,792.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
206,375,320.51 |
| Other Current Assets |
185,241,044.93 |
| Total Current Assets |
7,279,909,743.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
38,254,263.48 |
| Long-term Equity Investment |
409,058,508.56 |
| Investment Properties |
57,932,962.66 |
| Fixed Assetes |
3,488,598,148.84 |
| Under-construction Projects |
547,126,945.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
145,144,960.48 |
| R&D expenses |
-- |
| Goodwill |
22,317,196.76 |
| Long-Term Deferred and Prepaid Expenses |
20,707,443.51 |
| Deferred Income Tax Assets |
66,555,948.27 |
| Other Non-Current Assets |
526,594,497.97 |
| Sub-Total of Non-Current Assets |
5,948,528,418.15 |
| Total Assets |
13,228,438,161.59 |
| Short-Term Loans |
856,955,441.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
724,621,222.14 |
| Accounts Payable |
960,836,454.78 |
| Accounts Received In Advance |
326,333.32 |
| Employee Compensation Payable |
20,313,704.91 |
| Taxes Payable |
50,244,513.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
213,932,732.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
234,286,096.73 |
| Other Current Liabilities |
183,193,180.29 |
| Sub-Total of Current Liabilities |
3,667,361,677.73 |
| Long-term Loans |
1,295,451,745.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,128,434,647.49 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,058,911.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,591,655,113.15 |
| Total Liabilities |
6,259,016,790.88 |
| Paid-In Capital(Or Share Stock) |
2,327,508,476.00 |
| Capital Surplus |
432,542,502.43 |
| Surplus Reserve |
317,809,782.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,476,967,648.63 |
| Minority Stockholder's Interest |
389,621,809.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,579,799,561.55 |
| Owner's Equity（Stockholder's Equity） |
6,969,421,370.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,228,438,161.59 |
